Search results
Results from the WOW.Com Content Network
Henrietta Lacks (born Loretta Pleasant; August 1, 1920 – October 4, 1951) [2] was an African-American woman [5] whose cancer cells are the source of the HeLa cell line, the first immortalized human cell line [B] and one of the most important cell lines in medical research. An immortalized cell line reproduces indefinitely under specific ...
The book is about Henrietta Lacks and the immortal cell line, known as HeLa, that came from Lacks's cervical cancer cells in 1951. Skloot became interested in Lacks after a biology teacher referenced her but knew little about her. Skloot began conducting extensive research on her and worked with Lacks' family to create the book.
In 2021, Henrietta Lacks's estate sued to get past and future payments for the alleged unauthorized and widely known sale of HeLa cells by Thermo Fisher Scientific. [23] Lacks's family hired an attorney to seek compensation from upwards of 100 pharmaceutical companies that have used and profited from HeLa cells. [ 24 ]
As a cancer researcher who uses HeLa cells in my everyday work, even I sometimes find it hard to believe. On Aug. 1, 2023, over 70 years after doctors took Lacks’ cells without her consent or ...
HeLa cells went on to become a cornerstone of modern medicine, enabling countless scientific and medical innovations, including the development of the polio vaccine, genetic mapping and even COVID ...
Lacks’ cells, since named “HeLa” cells (to represent the first two letters of her first and last names) would prove foundational in future medical research and innovation.
On Tuesday, Henrietta Lacks’ family settled their lawsuit with biotechnology company Thermo Fisher Scientific, which reportedly profited from the use of Lacks’ cells in biomedical research ...
The family of Henrietta Lacks agreed Monday to settle its lawsuit against Thermo Fisher Scientific, a Massachusetts-based biotechnology company that sold products derived from the Baltimore County ...